Search results
Kirkland & Ellis Advises Eli Lilly in $3.2 Billion Morphic Buy
Bloomberg Law· 7 hours agoKirkland & Ellis represented Eli Lilly & Co. in its $3.2 billion acquisition of biopharmaceutical company Morphic Holding Inc.
Kirkland & Ellis represented Eli Lilly & Co. in its $3.2 billion acquisition of biopharmaceutical company Morphic Holding Inc.